This post is also available in: Swedish 简体中文
Elos Medtech’s dividend policy stipulates that the dividend is to be based on the Group’s earnings performance, while taking into account its future development potential and financial position. The long-term goal is for the dividend to increase at a constant rate and to be equivalent to 30-50 per cent of the profit after tax.